Literature DB >> 140244

Properties of strains of Staphylococcus aureus in the 94, 96 complex.

E H Asheshov, A W Coe, A Porthouse.   

Abstract

Strains of Staphylococcus aureus that are lysed by typing phages 94 or 96, or by both phages, are usually resistant to lysis by other basic-set typing phages. They are, however, sensitive to several experimental phages and show a number of different lytic patterns when tested against these phages. These differences in susceptibility are due, in part, to immunity imposed by temperate phages carried by the different strains. Resistance to lysis by other basic-set phages was not due to prophage immunity, but to at least one restriction and modification system in such strains. Restrictionless mutants were isolated from one strain in several experiments. These showed an increased sensitivity to many basic-set phages. However, all of these mutants retained the ability to modify the phages to the characteristic "94, 96" specificity. Strains in the 94, 96 complex showed a remarkable homogeneity in biological traits. The majority were non-pigmented, and produced lipase, fibrinolysin, alpha and delta haemolysins and enterotoxin B. This homogeneity may well be a reflexion of the restriction and modification systems in these strains, that prevent the acquisition of genetic material from strains outside the complex. A new lytic group V is proposed for members of the 94, 96 complex.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 140244     DOI: 10.1099/00222615-10-2-171

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  12 in total

1.  Typing of methicillin resistant and susceptible Staphylococcus aureus strains by ribosomal RNA gene restriction patterns using a biotinylated probe.

Authors:  L Preheim; D Pitcher; R Owen; B Cookson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-05       Impact factor: 3.267

2.  Clonal study of enterotoxin-B producing strains of Staphylococcus aureus.

Authors:  F Renaud; N Bornstein; H Meugnier; F Forey; M Bes; J Fleurette
Journal:  Epidemiol Infect       Date:  1994-06       Impact factor: 2.451

3.  A second site-specific restriction endonuclease from Staphylococcus aureus.

Authors:  J S Sussenbach; P H Steenbergh; J A Rost; W J van Leeuwen; J D van Embden
Journal:  Nucleic Acids Res       Date:  1978-04       Impact factor: 16.971

4.  Crystal violet reactions of fresh clinical isolates of Staphylococcus aureus from two British hospitals.

Authors:  R Freeman; S J Hudson; D Burdess
Journal:  Epidemiol Infect       Date:  1990-12       Impact factor: 2.451

5.  Numerical analysis of electrophoretic protein patterns of methicillin-resistant strains of Staphylococcus aureus.

Authors:  M Costas; B D Cookson; H G Talsania; R J Owen
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

6.  Borderline methicillin-susceptible Staphylococcus aureus strains have more in common than reduced susceptibility to penicillinase-resistant penicillins.

Authors:  O Massidda; M P Montanari; M Mingoia; P E Varaldo
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

7.  Computer analysis of Staphylococcus aureus phage typing data from 1957 to 1975, citing epidemiological trends and natural evolution within the phage typing system.

Authors:  C H Zierdt; E A Robertson; R L Williams; J D MacLowry
Journal:  Appl Environ Microbiol       Date:  1980-03       Impact factor: 4.792

8.  Enterotoxin production, phage typing and serotyping of Staphylococcus aureus strains isolated from clinical materials and food.

Authors:  A K Melconian; Y Brun; J Fleurette
Journal:  J Hyg (Lond)       Date:  1983-10

9.  Ribotyping of Staphylococcus aureus: an assessment using well-defined strains.

Authors:  J F Richardson; P Aparicio; R R Marples; B D Cookson
Journal:  Epidemiol Infect       Date:  1994-02       Impact factor: 2.451

10.  Enterotoxins and toxic-shock syndrome toxin-1 in non-enteric staphylococcal disease.

Authors:  R R Marples; A A Wieneke
Journal:  Epidemiol Infect       Date:  1993-06       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.